베바시주맙이 섬유주세포의 생존과 일산화질소의 생성에 미치는 영향

Effect of Bevacizumab on Survival and Production of Nitric Oxide in Trabecular Meshwork Cells

Purpose: To investigate the effect of bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), on the survival and production of nitric oxide (NO) in human trabecular meshwork cells (HTMC). Methods: Primarily cultured HTMC were exposed to 0, 0.25, 1.0, and 2.5 mg/ml bevacizumab for 24 hours. Cellular survival and production of NO were assessed by MTT assay and Griess assay, respectively. Results: Bevacizumab did not affect the cellular survival at low concentrations but decreased cellular survival significantly at high concentrations (>1.0 mg/ml) accompanied with increased NO production. Conclusions: High concentrations of bevacizumab may be toxic to HTMC.